.png)
Next-Gen Tumor Models
Patient Mimicking 3D Tumor Models for Research & Drug Development.
Current Clinical Challenge
Right now close to 95% of new cancer drugs fail during clinical trials. Drug development has also become slower and more expensive over time in a phenomenon known as Erooms Law, meaning fewer and fewer drugs are making it to market. One of the root causes of these problems is that the tools researchers use for drug testing and basic research, such as 2D cell cultures and mouse models, do not accurately depict human biology.
OUR SOLUTION
TUMOROIDS-ON-A-CHIP
EZ-Seed Plate
ADVANTAGES
-
One step cell seeding.
-
Monosize spheroids for experimental consistency.
-
Effortless immunostaining and imaging.
-
Platform is directly embeddable in paraffin for IHC and H&E analysis.
3-in-1 Plate
ADVANTAGES
-
Tumor models + extracellular matrix + drug testing. All-in-one platform.
-
Co-culture compatible.
-
Reduced cell requirements.
-
Test multiple conditions in parallel.
-
Monosize tumoroids for experimental consistency.
-
Effortless immunostaining and imaging.
-
Platform is directly embeddable in paraffin for IHC and H&E analysis.
Academic and Industrial Clients for
Beta Testing
Research Institutes and Universities
10
Pre-clinical CROs
2
Pharma and Drug Developers
1
What Are Tumoroids?
Tumoroids are three dimensional clusters of tumor cells grown in vitro. These structures mimic important aspects of the tumor microenvironment such as cell-cell and cell-matrix interactions, making them important models for both basic cancer research and drug testing. They are also amenable to a wide variety of assays and cancer/cell types.
Rewriting Erooms Law.
